The Role of Community Pharmacy in Post Discharge Management of Patients Initiated on Warfarin
The use of warfarin, particularly in the elderly for stroke prevention in chronic atrial fibrillation, is steadily increasing. While the benefits of warfarin are greatest in the elderly, so are the risk of adverse outcomes and the difficulties of anticoagulant management. Clinical systems need to improve to counter this therapeutic dilemma, as warfarin is likely to remain the only widely available oral anticoagulant for the foreseeable future.
This project is a participant based study
Related Diseases
Staff
Team Leaders
Local Collaborators
- Dr Luke Bereznicki
- Dr Shane Jackson
- Professor Greg Peterson
External Collaborators
- Dr Manya Angley - University of South Australia
- Dr Beata Bajorek
- Luigi Gaetani
- Professor Andrew McLachlan - University of Sydney
- Associate Professor Gary Misan - University of South Australia
- Dr Judy Mullan